Home › Forums › Continuing education › Pain Control in Dentistry
Welcome Dear Guest
To create a new topic please register on the forums. For help contact : discussdentistry@hotmail.com
- This topic has 5 replies, 3 voices, and was last updated 11/11/2012 at 5:07 pm by
Drsumitra.
-
AuthorPosts
-
01/07/2010 at 3:24 am #13972
divyanshee
OfflineRegistered On: 24/04/2010Topics: 25Replies: 38Has thanked: 0 timesBeen thanked: 0 times14/10/2012 at 12:55 pm #16034Drsumitra
OfflineRegistered On: 06/10/2011Topics: 238Replies: 542Has thanked: 0 timesBeen thanked: 0 timesTrauma to the teeth can be transmitted to the supporting structures, which get damaged. This can cause mobility of the teeth. Such mobile teeth may require splinting for a specified period of time till the supporting tissues heal and the tooth becomes stable.
Splinting is a procedure where the teeth are supported in its position for a period of time. This is done to teeth that are traumatized or teeth whose supporting structures are affected by disease, which prevents them from supporting the teeth. Splinting involves binding a group of teeth together so that the biting forces are shared by a large number of teeth instead of being born by the affected tooth.
Extremely thin fiber-glass band (0.05 mm / .0019") to be used with our Fiber-Bond or any light-cured bonding agents. The band is 4mm wide, which gives 30% more adhesion power to the interdental area. Indicated for periodontally loosened teeth, post-traumatic mobility, surgical reimplantation, or even to reinforce temporary bridges. It can also be used as splinting material for orthodontic stabilization. Strength with a certain degree of flexibility and “tooth hugging” quality combine for an overall aesthetic and functional result. Minimum tooth preparation.
High patient acceptance.15/10/2012 at 4:53 pm #16044Drsumitra
OfflineRegistered On: 06/10/2011Topics: 238Replies: 542Has thanked: 0 timesBeen thanked: 0 timesThe ideal sedative for oral surgery should make the patient comfortable during the surgery and should wear off quickly enough that the patient can leave the dental chair soon after the procedure. Finding the best plan of anesthetic treatment is essential to the success of dental procedures such as the extraction of wisdom teeth.
A study in the journal Anesthesia Progress compares two drug combinations for use as deep sedation during oral surgery. Patients in a control group received a continuous intravenous infusion of propofol-remifentanil, while those in an experimental group received a continuous intravenous infusion of propofol-ketamine. This was a double-blinded study — neither patients nor surgeons were aware of which treatment was given.
Oral surgery to extract third molars, also known as wisdom teeth, is a common dental procedure routinely performed with local anesthesia and moderate or deep sedation. This procedure is typically performed in the dental office, not a hospital setting, so there are not extensive facilities and personnel to assist in recovery. Rapid recovery for safe discharge is therefore an important component of dental anesthesia.
In the current study, 37 patients were monitored while sedated for respiratory, heart rate, and blood pressure stability. Emergence from the effects of anesthesia and total recovery time were recorded. Both patients and surgeons were asked to rate their satisfaction with the anesthetic treatments.
Patients who received the ketamine treatment took longer to emerge from the effects of the anesthesia. Their average emergence time was 13.6 minutes compared with 7.1 minutes for patients in the remifentanil group. The recovery period for ketamine patients was 42.9 minutes compared with 24.5 minutes for those who received remifentanil.
Both groups showed similar levels of sedation. However, an increase in heart rate was noted among patients receiving the ketamine treatment. Both patients and surgeons indicated they were very satisfied with either treatment.
While ketamine provides a more cost-effective alternative for dental sedation — remifentanil is more expensive — it requires a longer patient recovery time. This study found that the more rapid recovery from the propofol-remifentanil combination makes it a more ideal deep sedative for dental office third molar surgery.29/10/2012 at 5:50 pm #16100Drsumitra
OfflineRegistered On: 06/10/2011Topics: 238Replies: 542Has thanked: 0 timesBeen thanked: 0 timesA new study comparing the effectiveness of propofol-remifentanil and propofol-ketamine combinations for the removal of all four third molars found that the latter is a less-than-perfect alternative to the former, primarily due to recovery times (Anesthesia Progress, Fall 2012, Vol. 59:3, pp. 107-117).
The prospective, randomized, double-blinded controlled study was performed by researchers from Indiana University (IU); University of California, Los Angeles; and Ohio State University (OSU)."The biggest difference that we found was that the group that received ketamine and propofol as an infusion took basically twice as long to emerge from anesthesia," Kyle Kramer, DDS, a visiting professor at the department of oral surgery and hospital dentistry at IU’s School of Dentistry, said in an interview with DrBicuspid.com. "And it took patients twice as long to recover fully and meet discharge criteria."
“It took patients twice as long to recover fully and meet discharge criteria.”
— Kyle Kramer, DDS, Indiana University
Recovery time was the primary difference noted in the measured outcomes tracked by the researchers. Other measured outcomes included various sedation parameters, hemodynamic and respiratory stability, patient and surgeon satisfaction, postoperative course, and associated drug costs."What we found is that the operating conditions were pretty similar," Dr. Kramer said. "There weren’t a lot of differences interoperatively."
‘Remarkable stability’
The study’s 37 participants were men and nonpregnant women between the ages of 18 and 40 who were active patients in the department of oral and maxillofacial surgery at OSU’s College of Dentistry. Due to the possible psychotomimetic effects of ketamine, patients with a history of psychiatric or psychological conditions were excluded. Prior to receiving one of the two sedative combinations, each patient was given midazolam (0.03 mg/kg) to achieve baseline sedation.
Those that received propofol-remifentanil in ratios of 20 mg of propofol to 5 µg of remifentanil per milliliter served as the control group. The experimental group was given a combination of propofol-ketamine in a ratio of 10 mg of propofol to 2.5 mg of ketamine per milliliter; both were given at an initial propofol infusion rate of 100 µg/kg/minute.
After the extractions were performed and the infusions terminated, clinicians tried to revive patients by gently shaking their shoulder and asking the patients to open their eyes every minute until there was a response. This determined the emergence time. Recovery time was qualified by the patients’ ability to complete the same Trieger connect-the-dots test and 30-second one-leg standing test they completed prior to the surgery.
Surgeons were asked to rate their satisfaction immediately after the surgery, while patients were contacted by phone the following day. The patients were also asked about postoperative nausea and vomiting (PONV) during the call.
The researchers found no statistical difference in the mean infusion times or rates.
"Both groups demonstrated similar sedation parameters and hemodynamic and respiratory stability," they wrote.
Drug shortages and recalls
However, the ketamine group had prolonged emergence (13.6 ± 6.6 versus 7.1 ± 3.7 minus, p = 0.0009) and recovery (42.9 ± 18.7 versus 24.7 ± 7.6 minutes, p = 0.0004) times.
The researchers found no statistical differences in patient or surgeon satisfaction, postoperative oral analgesic requirements, or PONV between the two groups. They also found "remarkable hemodynamic and respiratory stability" for both groups.
Kenneth K. Lee, DDS, a Los Angeles practitioner who has written about propofol, agreed with the study findings and highlighted aspects of it that are relevant to the typical practitioner.
"The conclusions are valid; ketamine is a longer-acting drug, hence you will get longer recovery time," Dr. Lee stated in an email to DrBicuspid.com. "For a busy office, this fact alone would probably preclude its use."
However, forces outside dentists’ control may lead to them to consider using a propofol-ketamine combination.
"In these days of drug shortages and recalls, it is prudent for practitioners to have a variety of techniques in their armamentarium," Dr. Lee explained. "Both techniques are good ones but are only viable for those that carry a general anesthesia permit or who have completed an oral and maxillofacial surgery or dental anesthesiology residency."
Given the environment of cost-conscious healthcare, the relatively high cost of remifentanil compared with that of ketamine may favor the use of ketamine as a more cost-effective anesthetic alternative to remifentanil while still allowing for good sedation quality and recovery parameters, the researchers noted.
11/11/2012 at 5:07 pm #16160Drsumitra
OfflineRegistered On: 06/10/2011Topics: 238Replies: 542Has thanked: 0 timesBeen thanked: 0 timesGerman researchers have found a way to add a light-sensitive moiety to propofol that could control its effect on humans with light (Angewandte Chemie International Edition, October 15, 2012, Vol. 51:42, pp. 10500-10504).
In their study, the researchers from Ludwig Maximilian University (LMU) of Munich effectively anesthetized and revived tadpoles when irradiated with violet light. The tadpoles returned to their anesthetized state when the light was switched off, suggesting a reversible light-dependent effect.Propofol’s effectiveness lies in its interaction with receptors on neural cell membranes that typically bind the inhibitory neurotransmitter gamma-aminobutyric acid (GABA), the study authors noted. While propofol has been studied since its discovery in 1980, there are persistent gaps in the knowledge of its function, they added.
"The analysis of their exact binding sites at a molecular level has been complicated by a lack of detailed structural data," they wrote. The data from their study suggest new ways to harness propofol’s functionality.
"[We learned] that GABA receptors, which control inhibitory input in the brain and retina, can be controlled with light," study author Dirk Trauner, PhD, a professor of chemical biology and genetics at LMU, wrote in an email to DrBicuspid.com. Trauner, specializes in enabling "blind" nerve cells to react to light stimulation, according to an LMU press release.
Azobenzene derivatives of propofol
Trauner and his fellow researchers from the U.S. and Switzerland designed a series of azobenzene derivatives of propofol, called azo-propofols, that allow the action of the GABA receptor to be regulated by light.
One of the azo-propofols in particular, called AP2, had favorable pharmacological and photochemical features. Additionally, the molecular switch that was attached to the azo-propofol actually made it a more potent anesthetic in the dark.
The researchers established that AP2 had an impact on GABAA receptors, pentameric ligand-gated ion channels that are activated by GABA, and moved forward to investigate the light dependency of the current potentiation. They used pocket lights of different wattages to test egg yolk cells where GABA was coapplied with AP2 with promising results. "The current amplitude decreased rapidly and increased again upon turning off the light source," the researchers wrote.
Afterward, they tested the anesthetic activity and photoreversability of propofol and AP2 in animal models using tadpoles. The researchers noted that light "induced vigorous swimming activity in unanesthetized tadpoles," suggesting that it is a noxious stimulus. They places groups of the animals in solutions containing propofol or AP2 and tested them every five minutes for loss of righting reflexes (LORR), which is a standard assay for anesthesia, the researchers noted.
More research needed
The animals exposed to propofol were anesthetized as anticipated. In AP2, the animals expressed similar EC50 value (a measure of a drug’s potency) to propofol, but light changed the value considerably.
"Propofol produced LORR in all tadpoles with or without light, whereas in AP2, all animals showed LORR without light and all spontaneously righted themselves during illumination with UV light," the researchers wrote. The demonstration supports a hypothesis of the researchers that "anesthesia caused by AP2 and propofol is largely mediated by GABAA receptors."
While the study’s results are intriguing, considerable work needs to be done before dentists use a type of light-controlled propofol in their practices, Trauner noted.
"I think controlling the human brain and consciousness with light would be illusionary at this stage," he told DrBicuspid.com.
He was more optimistic that the data could be applied to vision restoration in the near future. In the next phase of his research, he said that he will apply their compounds to the retina to restore vision and see whether certain brain nuclei in rats can be made light-sensitive.
-
AuthorPosts
- You must be logged in to reply to this topic.